Li Peifeng

Li Peifeng is a distinguished Professor and Dean at the Institute of Translational Medicine, College of Medicine, Qingdao University, China. He also serves as Director of the Key Laboratory of Nucleic Acid Biology in Cardiovascular Disease (Shandong) and the International Research Centre for Non-coding RNAs and Translational Medicine (Qingdao). His academic career includes roles as Distinguished Professor at the Chinese Academy of Sciences (2006–2013) and a Medical Researcher at the Max-Delbrück-Center for Molecular Medicine in Berlin (1995–2005).

Li Peifeng holds an MD and PhD from the Chinese Academy of Medical Science (1990–1993). His research focuses on cardiovascular biology, non-coding RNAs, and molecular mechanisms underlying myocardial infarction, heart failure, and apoptosis. He has led groundbreaking studies on miRNA regulation in cardiac pathologies and oxidative stress responses.

Notable awards include the World’s Top 2% Scientists (2020), Highly Cited Chinese Researchers (2020), and multiple national and provincial accolades. He is an editorial board member for journals like Molecular Biotechnology and Circulation Research, and has reviewed grants for institutions including the European Research Council and the American Heart Association.

• Awards: Taishan Scholar (2018), Leading Innovative Scientist (2018), Tip-top Talent (2017).
• Leadership Roles: Organized major conferences, including the Annual Conference on Cell Biology (2018) and International Cardiology Conferences (2014–2015).
• Key Labs: Directs research centers focused on nucleic acid biology and non-coding RNAs in cardiovascular disease.